申请人:Zhang Zhichao
公开号:US20130123492A1
公开(公告)日:2013-05-16
The present invention relates to acenaphtho heterocyclic compounds and their uses in manufacturing the BH3 mimetics as Bcl-2-like protein inhibitors. Structures are shown in the following:
Statistical analysis of their bio-activities showed these compounds exhibit better BH3 mimicking property than the reported compounds. These compounds can simulate BH3-only protein, competitively bind and antagonizing Bcl-2 and Mcl-1 proteins in vitro and in cells, and then induce apoptosis. Therefore, they all can be used in the manufactures of anticancer compounds.
本发明涉及蒽醌杂环化合物及其在制造类似Bcl-2蛋白抑制剂的BH3模拟物中的用途。结构如下所示:对它们的生物活性进行的统计分析表明,这些化合物表现出比已报告的化合物更好的BH3模拟性能。这些化合物可以模拟BH3-只蛋白,在体外和细胞中与Bcl-2和Mcl-1蛋白竞争性结合和拮抗,然后诱导细胞凋亡。因此,它们都可以用于抗癌化合物的制造。